New drug aims to power up brain cells in Parkinson's
Disease control
Not yet recruiting
This study is testing whether a new oral drug called SUL-238 can improve the energy function of brain cells in people with early, untreated Parkinson's disease. Researchers will compare two doses of SUL-238 against a placebo in 45 participants over a 28-day treatment period. The …
Phase: PHASE2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC